{"DataElement":{"publicId":"6063732","version":"1","preferredName":"CDKN2A Gene Mutant Protein Identified Type","preferredDefinition":"Text term that represents the specific kind of CDKN2A gene mutant protein identified.","longName":"CDKN2A_mutation","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6063533","version":"1","preferredName":"CDKN2A Gene Mutant Protein Identification","preferredDefinition":"This gene functions as a tumor suppressor and transcriptional regulator._A protein with an amino acid sequence that differs from the wildtype, canonical sequence._The procedure of having an identity established.","longName":"3183684v1.0:6101599v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"3183684","version":"1","preferredName":"CDKN2A Gene","preferredDefinition":"This gene functions as a tumor suppressor and transcriptional regulator.","longName":"C18022","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A Gene","conceptCode":"C18022","definition":"This gene functions as a tumor suppressor and transcriptional regulator.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A11FE92-A006-D9BE-E040-BB89AD436441","latestVersionIndicator":"Yes","beginDate":"2011-01-17","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-01-17","modifiedBy":"ONEDATA","dateModified":"2011-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6101599","version":"1","preferredName":"Mutant Protein Identification","preferredDefinition":"A protein with an amino acid sequence that differs from the wildtype, canonical sequence.:The procedure of having an identity established.","longName":"C147118:C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mutant Protein","conceptCode":"C147118","definition":"A protein with an amino acid sequence that differs from the wildtype, canonical sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66ABA3FA-C72E-36DE-E053-F662850A178D","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-05","modifiedBy":"ONEDATA","dateModified":"2018-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64A4B2B4-7D09-6584-E053-F662850AA02E","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6063694","version":"1","preferredName":"CDKN2A Protein Variant Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6063694v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other (specify)","valueDescription":"Specify Other","ValueMeaning":{"publicId":"2770998","version":"1","preferredName":"Specify Other","longName":"2770998","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F45DBF-5E42-1D6F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"MAESKEB","dateCreated":"2008-08-08","modifiedBy":"COOPERM","dateModified":"2018-02-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-7954-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"A148T","valueDescription":"CDKN2A NP_000068.1:p.A148T ","ValueMeaning":{"publicId":"6063695","version":"1","preferredName":"CDKN2A NP_000068.1:p.A148T ","longName":"6063695","preferredDefinition":"A change in the amino acid residue at position 148 in the cyclin-dependent kinase inhibitor 2 protein where alanine has been replaced by threonine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A NP_000068.1:p.A148T","conceptCode":"C146950","definition":"A change in the amino acid residue at position 148 in the cyclin-dependent kinase inhibitor 2 protein where alanine has been replaced by threonine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-795E-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-7977-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"A147T","valueDescription":"CDKN2A NP_000068.1:p.A147T","ValueMeaning":{"publicId":"6063696","version":"1","preferredName":"CDKN2A NP_000068.1:p.A147T","longName":"6063696","preferredDefinition":"A change in the amino acid residue at position 147 in the cyclin-dependent kinase inhibitor 2 protein where alanine has been replaced by threonine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A NP_000068.1:p.A147T","conceptCode":"C146948","definition":"A change in the amino acid residue at position 147 in the cyclin-dependent kinase inhibitor 2 protein where alanine has been replaced by threonine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-7981-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-799A-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"L130Q","valueDescription":"CDKN2A NP_000068.1:p.L130Q","ValueMeaning":{"publicId":"6063697","version":"1","preferredName":"CDKN2A NP_000068.1:p.L130Q","longName":"6063697","preferredDefinition":"A change in the amino acid residue at position 130 in the cyclin-dependent kinase inhibitor 2 protein where leucine has been replaced by glutamine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A NP_000068.1:p.L130Q","conceptCode":"C146946","definition":"A change in the amino acid residue at position 130 in the cyclin-dependent kinase inhibitor 2 protein where leucine has been replaced by glutamine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-79A4-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-79BD-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"D108Y","valueDescription":"CDKN2A NP_000068.1:p.D108Y","ValueMeaning":{"publicId":"6063698","version":"1","preferredName":"CDKN2A NP_000068.1:p.D108Y","longName":"6063698","preferredDefinition":"A change in the amino acid residue at position 108 in the cyclin-dependent kinase inhibitor 2 protein where aspartic acid has been replaced by tyrosine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A NP_000068.1:p.D108Y","conceptCode":"C146944","definition":"A change in the amino acid residue at position 108 in the cyclin-dependent kinase inhibitor 2 protein where aspartic acid has been replaced by tyrosine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-79C7-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-79E0-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"D108H","valueDescription":"CDKN2A NP_000068.1:p.D108H","ValueMeaning":{"publicId":"6063699","version":"1","preferredName":"CDKN2A NP_000068.1:p.D108H","longName":"6063699","preferredDefinition":"A change in the amino acid residue at position 108 in the cyclin-dependent kinase inhibitor 2 protein where aspartic acid has been replaced by histidine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A NP_000068.1:p.D108H","conceptCode":"C146942","definition":"A change in the amino acid residue at position 108 in the cyclin-dependent kinase inhibitor 2 protein where aspartic acid has been replaced by histidine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-79EA-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-7A03-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"H83P","valueDescription":"CDKN2A NP_000068.1:p.H83P","ValueMeaning":{"publicId":"6063700","version":"1","preferredName":"CDKN2A NP_000068.1:p.H83P","longName":"6063700","preferredDefinition":"A change in the amino acid residue at position 83 in the cyclin-dependent kinase inhibitor 2 protein where histidine has been replaced by proline.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A NP_000068.1:p.H83P","conceptCode":"C146938","definition":"A change in the amino acid residue at position 83 in the cyclin-dependent kinase inhibitor 2 protein where histidine has been replaced by proline.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-7A0D-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-7A26-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"H83Y","valueDescription":"CDKN2A NP_000068.1:p.H83Y","ValueMeaning":{"publicId":"6063701","version":"1","preferredName":"CDKN2A NP_000068.1:p.H83Y","longName":"6063701","preferredDefinition":"A change in the amino acid residue at position 83 in the cyclin-dependent kinase inhibitor 2 protein where histidine has been replaced by tyrosine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A NP_000068.1:p.H83Y","conceptCode":"C146934","definition":"A change in the amino acid residue at position 83 in the cyclin-dependent kinase inhibitor 2 protein where histidine has been replaced by tyrosine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-7A30-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-7A49-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"V51I","valueDescription":"CDKN2A NP_000068.1:p.V51I","ValueMeaning":{"publicId":"6063702","version":"1","preferredName":"CDKN2A NP_000068.1:p.V51I","longName":"6063702","preferredDefinition":"A change in the amino acid residue at position 51 in the cyclin-dependent kinase inhibitor 2 protein where valine has been replaced by isoleucine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A NP_000068.1:p.V51I","conceptCode":"C146932","definition":"A change in the amino acid residue at position 51 in the cyclin-dependent kinase inhibitor 2 protein where valine has been replaced by isoleucine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-7A53-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-7A6C-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"V51D","valueDescription":"CDKN2A NP_000068.1:p.V51D","ValueMeaning":{"publicId":"6063703","version":"1","preferredName":"CDKN2A NP_000068.1:p.V51D","longName":"6063703","preferredDefinition":"A change in the amino acid residue at position 51 in the cyclin-dependent kinase inhibitor 2 protein where valine has been replaced by aspartic acid.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A NP_000068.1:p.V51D","conceptCode":"C146930","definition":"A change in the amino acid residue at position 51 in the cyclin-dependent kinase inhibitor 2 protein where valine has been replaced by aspartic acid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-7A76-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-7A8F-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"},{"value":"A30V","valueDescription":"CDKN2A NP_000068.1:p.A30V","ValueMeaning":{"publicId":"6063704","version":"1","preferredName":"CDKN2A NP_000068.1:p.A30V","longName":"6063704","preferredDefinition":"A change in the amino acid residue at position 30 in the cyclin-dependent kinase inhibitor 2 protein where alanine has been replaced by valine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDKN2A NP_000068.1:p.A30V","conceptCode":"C146928","definition":"A change in the amino acid residue at position 30 in the cyclin-dependent kinase inhibitor 2 protein where alanine has been replaced by valine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-7A99-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"64AB8F25-7AB2-0BE8-E053-F662850A3DB5","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"ONEDATA","dateModified":"2018-02-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AB8F25-793C-0BE8-E053-F662850A3DB5","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"5777527","version":"1","longName":"Pancreatic","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If CDKN2A mutation identified","type":"Preferred Question Text","description":"If CDKN2A mutation identified, which one?","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64AC60B8-5EDD-5301-E053-F662850A1209","latestVersionIndicator":"Yes","beginDate":"2018-02-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-07","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeDescription":"Created for molecular marker request 1/31/18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}